Training scientists to advance cancer research and treatment
Cancer Biology Training Program (CBTP)
['FUNDING_TRAINING'] · GEORGE WASHINGTON UNIVERSITY · NIH-10875509
The George Washington Cancer Biology Training Program is designed to help new scientists learn about the genes and molecules that cause cancer, giving them hands-on experience and training to develop new treatments, while also focusing on improving cancer care for everyone in Washington, D.C.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GEORGE WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (WASHINGTON, UNITED STATES) |
| Trial ID | NIH-10875509 on ClinicalTrials.gov |
What this research studies
The George Washington Cancer Biology Training Program (GW-CBTP) aims to educate and train scientists to explore the molecular and genomic factors that contribute to cancer. This program offers a two-year individualized training experience for postdoctoral and predoctoral trainees, combining hands-on research projects with coursework on innovative cancer therapies. Trainees will work alongside expert researchers and clinicians, gaining valuable skills in grant writing and professional development. The program also focuses on addressing cancer health disparities in the District of Columbia.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals interested in pursuing careers in cancer research or those affected by cancer who may benefit from advancements in treatment.
Not a fit: Patients who are not involved in research training or who do not have a direct interest in cancer research may not receive benefits from this program.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment of various cancers, ultimately benefiting patients through enhanced therapies and reduced health disparities.
How similar studies have performed: Similar training programs have successfully advanced cancer research and education, contributing to significant improvements in cancer treatment and understanding.
Where this research is happening
WASHINGTON, UNITED STATES
- GEORGE WASHINGTON UNIVERSITY — WASHINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LEE, NORMAN H — GEORGE WASHINGTON UNIVERSITY
- Study coordinator: LEE, NORMAN H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Biology